Should electrochemiluminiscence immunoassay (ECLIA) tests be used in the…
For any questions or information, please email covidrapidreviewteam@gmail.com.
ECLIA 20200823_180625For any questions or information, please email covidrapidreviewteam@gmail.com.
ECLIA 20200823_180625For any questions or information, please email: covidrapidreviewteam@gmail.com.
RAgT_SR_22Aug2020_V4 Final> NOTE: The COVID-19 Living Clinical Practice Guidelines contains UPDATED recommendations and evidence summaries. Click here to be redirected to the COVID LCPG.
This Interim Guidance on the Clinical Management of Adult Patients with Suspected or Confirmed COVID-19 Infection (Version 3.1) is an update of the March 31, 2020 guidelines released by the Philippine Society for Microbiology and Infectious Diseases. New evidence have been published since then necessitating this update.This document is written to guide clinicians and health care workers in their COVID-19 related management decisions. It is based on available scientific evidence that is also rapidly evolving, as more is discovered about the pathophysiology of SARS CoV-2 and the pathogenesis of the disease. As such, the recommendations in this guideline are based on limited, often low-quality evidence, and need to be carefully balanced with clinical judgment. The use of investigational drugs should be discussed with the patient or a legally authorized representative carefully outlining the potential adverse reactions and the potential clinical benefits of these investigational drugs. A signed informed consent should be obtained by the clinician.
DOWNLOAD the Interim Management Guidelines for COVID-19 (Version 3.1) here.
For any questions or information, please email covidrapidreviewteam@gmail.com.
Steam Inhalation for COVID Full Report 14JUL2020 V1 TU MM SA EU LFDFor any questions or information, please email covidrapidreviewteam@gmail.com.
Closed Suctioning Abridged 25June2020 V1.0For any questions or information, please email: covidrapidreviewteam@gmail.com.
SCHOOL CLOSURE ABRIDGED June 27 FINALFor any questions or information, please email: covidrapidreviewteam@gmail.com.
Mouthwash_prophylaxis_abridged 25June2020_V1_PMIFor any questions or information, please email: covidrapidreviewteam@gmail.com.
VitaminD_Abridged_report_22May2020 v1.2For any questions or information, please email: covidrapidreviewteam@gmail.com.
Probiotics_Abridged report_V1.13_June 1, 2020_RFG LFD2For any questions or information, please email: covidrapidreviewteam@gmail.com.
14 day SX Based Test 061520_1592192251